Inhibition of Plasmodium yoelii blood-stage malaria by interferon α through the inhibition of the production of its target cell, the reticulocyte

Blood

Volumn 97, Issue 12, 2001, Pages 3966-3971

  Vigário, Ana Margarida ^a,b,c,d,e   Belnoue, Elodie ^a,b,c,d,e   Cumano, Ana ^a,b,c,d,e   Marussig, Myriam ^a,b,c,d,e   Miltgen, François ^a,b,c,d,e   Landau, Irene ^a,b,c,d,e   Mazier, Dominique ^a,b,c,d,e   Gresser, Ion ^a,b,c,d,e   Rénia, Laurent ^a,b,c,d,e,f  

^a Université Paris Descartes   (France)

^b INSTITUT PASTEUR   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d MUSÉUM NATIONAL D'HISTOIRE NATURELLE   (France)

^e Institut de Recherches sur le Cancer   (France)

^f INSTITUT COCHIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT ALPHA INTERFERON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ERYTHROCYTE; ERYTHROPOIESIS; FEMALE; HEPATOSPLENOMEGALY; MALARIA; MOUSE; NONHUMAN; PLASMODIUM YOELII; PRIORITY JOURNAL; RETICULOCYTE; RETICULOCYTOSIS; TARGET CELL;

EID: 0035877961     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V97.12.3966     Document Type: Article

References (46)

1. World Health Organization. World malaria situation in 1994. Weekly Epidemiol Rec. 1997;72:269-276.
2. Ferreira A, Schofield L, Enea V, et al. Inhibition of development of exoerythrocytic forms of malaria parasites by gamma interferon. Science. 1986;232:881-884.
3. Maheshwari RK, Czarniecki CW, Dutta GP, Purl SK, Dhawan BN, Friedman RM. Recombinant human gamma interferon inhibits simian malaria. Infect Immun. 1986;53:628-630.
4. Mellouk S, Maheshwari RK, Rhodes-Feuillette A, et al. Inhibitory activity of interferons and interleukin 1 on the development of Plasmodium falciparum in human hepatocyte cultures. J Immunol. 1987;139:4192-4195.
5. Sedegah M, Finkelman F, Hoffman SL. Interleukin 12 induction of interferon gamma-dependent protection against malaria. Proc Natl Acad Sci U S A. 1994;91:10700-10702.
6. Hoffman SL, Crutcher JM, Puri SK, et al. Sterile protection of monkeys against malaria after administration of interleukin-12. Nat Med. 1997;3:80-83.
7. Stevenson MM, Tam MF, Wolf SF, Sher A. IL-12-induced protection against blood-stage Plasmodium chabaudi AS requires IFN-gamma and TNF-alpha and occurs via a nitric oxide-dependent mechanism. J Immunol. 1995;55:2545-2556.
8. Bogdan C. The function of type I interferons in antimicrobial immunity. Curr Opin Immunol. 2000;12:419-424.
9. Gobert JG, German A, Poindron P, Savel J. Interferon and protection of mice against experimental infestation transmitted by the blood forms of Plasmodium berghei injected in massive doses, I: methods of protection with a viral inducer of interferon [in French]. Ann Pharm Fr. 1971;29:521-528.
10. Jahiel RI, Vilcek J, Nussenzweig RS, Vanderberg JP. Interferon inducers protect mice against Plasmodium berghei malaria. Science. 1968;161:802-803.
11. Jahiel RI, Nussenzweig RS, Vanderberg JP, Vilcek J. Anti-malarial effect of interferon inducers at different stages of development of Plasmodium berghei in the mouse. Nature. 1968;220:710-711.
12. Jahiel RI, Nussenzweig RS, Vilcek J, Vanderberg JP. Protective effects on interferon inducers on Plasmodium berghai malaria. Am J Trop Med Hyg. 1969;18:823-835.
13. Schultz WW, Huang KY, Gordon FB. Role of interferon in experimental mouse malaria. Nature. 1968;220:709-710.
14. Jahiel RI, Vilcek J, Nussenzweig RS. Exogenous interferon protects mice against Plasmodium berghei malaria. Nature. 1970;227:1350-1351.
15. Cox FEG. A comparative account of the effects of betamethasone on mice infected with Plasmodium vinckei chabaudi and Plasmodium berghei yoelii. Parasitology. 1974;68:19-26.
16. Landau I, Killick-Kendrick R. Rodent plasmodia of the Republique Centrafricaine: the sporogony and tissue stages of Plasmodium chabaudi and P. berghei yoelii. Trans R Soc Trop Med Hyg. 1966;60:633-649.
17. Panton LJ, Knowles G, Walliker D. Studies of antigens in Plasmodium yoelii, I: antigenic differences between parasite lines detected by crossed immunoelectrophoresis. Parasitology. 1984;89:17-26.
18. Meister A, Uze G, Mogensen KE, et al. Biological activities and receptor binding of two human recombinant interferons and their hydrids. J Gen Virol. 1986;67:1633-1643.
19. Hulier E, Petour P, Snounou G, et al. A method for the quantitative assessment of malaria parasite development in organs of the mammalian host. Mol Biochem Parasitol. 1996;77:127-135.
20. Taverne J, Sheikh N, De Souza JB, Playfair JH, Probert L, Kollias G. Anaemia and resistance to malaria in transgenic mice expressing human tumour necrosis factor. Immunology. 1994;82:397-403.
21. Fahey JR, Spitalny GL. Virulent and nonvirulent forms of Plasmodium yoelii are not restricted to growth within a single erythrocyte type. Infect Immun. 1984;44:151-156.
22. Swardson CJ, Wassom DL, Avery AC. Plasmodium yoelii: resistance to disease is linked to the mtv-7 locus in BALB/c mice. Exp Parasitol. 1997;86:102-109.
23. Ryder EF, Robakiewicz P. Statistics for the molecular biologists: group comparisons. In: Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W, eds. Current Protocols in Molecular Biology. New York, NY: John Wiley and Sons; 1998:A.31.1.-A.31.20.
24. Moore MAS, Metcalf D. Ontogeny of the hemopoietic system: yolk sac origin of in vitro and in vivo colony forming cells in the developing mouse embryo. Br J Haematol. 1970;18:279-296.
25. Iscove NN, Schreier MH. Clonal growth of cells in semisolid or viscous medium. In: Lefkovitz I, Pernis B, eds. Immunological Methods. New York, NY: Academic Press; 1979:379-384.
26. Zuckerman A. Current status of the immunology of blood and tissue protozoa, II: Plasmodium. Exp Parasitol. 1977;42:374-446.
27. Van Damme J, Schaafsma WR, Fibbe WE, Falkenburg JHF, Opdenakker G, Billiau A. Simultaneous production of interleukin 6, interferon-beta and colony-stimulating activity by fibroblasts after viral and bacterial infection. Eur J Immunol. 1989;19:163-168.
28. Pied S, Civas A, Berliot-Picard F, et al. IL-6 induced by IL-1 inhibits malaria pre-erythrocytic stages but its secretion is down-regulated by the parasite. J Immunol. 1992;148:197-201.
29. Vreden SGS, van den Broek MF, Oettinger MC, Verhave JP, Meuwissen JH, Sauerwein RW. Cytokines inhibit the development of liver schizonts of the malaria parasite Plasmodium berghei in vivo. Eur J Immunol. 1992;22:2271-2275.
30. Binder D, Fehr J, Hengartner H, Zinkernagel RM. Virus-induced transient bone marrow aplasia: major role of interferon-α/β during acute infection with the noncytopathic lymphocytic choriomeningitis virus. J Exp Med. 1997;185:517-530.
31. Broxmeyer HE, Lu L, Platzer E, Feit C, Juliano L, Rubin BY. Comparative analysis of the influences of human gamma, alpha and beta interferons on human multipotential (CFU-GM) progenitor cells. J Immunol. 1983;131:1300-1305.
32. Means RT, Krantz SB. Inhibition of human erythroid colony-forming units by interferons alpha and beta: differing mechanisms despite shared receptor. Exp Hematol. 1996;24:204-208.
33. Raefsky EL, Platanias LC, Zoumbos NC, Young NS. Studies of interferon as a regulator of hematopoietic cell proliferation. J Immunol. 1985;135:2507-2512.
34. Tarumi T, Sawada K, Sato N, et al. Interferon-alpha-induced apoptosis in human erythroid progenitors. Exp Hematol. 1995;23:1310-1318.
35. Angulo I, Rodriguez R, Garcia B, Medina M, Navarro J, Subiza JL. Involvement of nitric oxide in marrow-derived natural suppressor activity: its dependence on IFN-γ. J Immunol. 1995;155:15-26.
36. Shami PJ, Weinberg JB. Differential effects of nitric oxide on erythroid and myeloid colony growth from CD34+ human bone marrow cells. Blood. 1966;87:977-982.
37. Zoumbos NC, Dieu JY, Young NS. Interferon is the suppressor of hematopoiesis generated by stimulated lymphocytes in vitro. J Immunol. 1984;133:769-774.
38. Kitchen SF. The infection of reticulocytes by Plasmodium vivax. Am J Hyg. 1937;27:347-354.
39. Galinski MR, Medina CC, Ingravallo P, Barnwell JW. A reticulocyte-binding protein complex of Plasmodium vivax merozoites. Cell. 1992;69:1213-1226.
40. Pasvol G, Weatherall DJ, Wilson RJM. The increased susceptibility of young red cells to invasion by the malarial parasite Plasmodium falciparum. Br J Haematol. 1980;45:285-295.
41. Kurane I, Innis BL, Nimmannitya S, Nisalak A, Meager A, Ennis FA. High levels of interferon alpha in the sera of children with dengue virus infection. Am J Trop Med Hyg. 1993;48:222-229.
42. Luty AJ, Perkins DJ, Lell B, et al. Low interleukin-12 activity in severe Plasmodium falciparum malaria. Infect Immun. 2000;68:3909-3915.
43. Ojo-Amaize EA, Salimonu LS, Williams AI, et al. Positive correlation between degree of parasitemia, interferon titers, and natural killer cell activity in Plasmodium falciparum-infected children. J Immunol. 1981;127:2296-2300.
44. Ronnblom L, Ojo-Amaize EA, Franzen L, Wigzell H, Alm GV. Plasmodium falciparum parasites induce interferon production in human peripheral blood 'null' cells in vitro. Parasite Immunol. 1983;5:165-172.
45. Rhodes-Feuillete A, Jaureguiberry G, Ballet JJ, et al. The interferon compartment of the immune response in human malaria, I: interferon inducers in Plasmodium falciparum cultures. J Interferon Res. 1985;5:159-168.
46. Bruce MC, Donnelly CA, Alpers MP, et al. Crossspecies interactions between malaria parasites in humans. Science. 2000;287:845-848.